Sugammadex 100 Mg/Ml Mylan 100 mg Solution for Injection
PDF Leaflet Revision Date: 22 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Routine and immediate reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Dosage (summary)
4 mg/kg for profound blockade, 2 mg/kg for shallow blockade, 16 mg/kg for immediate reversal.
Onset of Action / Duration
Onset: 3 mins, Duration: varies based on dose.
Special Populations
- Renal impairment
- Elderly patients
- Obese patients
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Caution in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Toremifene
- Fusidic acid
- Hormonal contraceptives
Contraindications
- Hypersensitivity to sugammadex or excipients
Common side effects
- Cough
- Dysgeusia
- Airway complications
- Procedural hypotension
Counselling Points
- Monitor for signs of recurrence of neuromuscular blockade.
- Caution with anticoagulants.
- Inform about potential hypersensitivity reactions.
Serious warnings
- Risk of recurrence of neuromuscular blockade
- Marked bradycardia
- Monitor respiratory function post-reversal
Important Disclaimer
The Sugammadex 100 Mg/Ml Mylan 100 mg Solution for Injection professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
